These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 7743475

  • 21. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
    Korkolopoulou P, Christodoulou P, Kouzelis K, Hadjiyannakis M, Priftis A, Stamoulis G, Seretis A, Thomas-Tsagli E.
    Br J Cancer; 1997; 75(9):1269-78. PubMed ID: 9155045
    [Abstract] [Full Text] [Related]

  • 22. Assessment of cellular proliferation of eccrine acrospiromas and eccrine sweat gland carcinomas by AgNOR counting and immunohistochemical demonstration of proliferating cell nuclear antigen (PCNA) and Ki-67.
    Ansai S, Koseki S, Hozumi Y, Kondo S.
    Clin Exp Dermatol; 1995 Jan; 20(1):27-34. PubMed ID: 7671392
    [Abstract] [Full Text] [Related]

  • 23. Characterization of the proliferation state in canine mammary tumors by the standardized AgNOR method with postfixation and immunohistologic detection of Ki-67 and PCNA.
    Löhr CV, Teifke JP, Failing K, Weiss E.
    Vet Pathol; 1997 May; 34(3):212-21. PubMed ID: 9163877
    [Abstract] [Full Text] [Related]

  • 24. Sarcomatoid renal cell carcinoma. A study of its proliferative activity.
    Oda H, Machinami R.
    Cancer; 1993 Apr 01; 71(7):2292-8. PubMed ID: 8095849
    [Abstract] [Full Text] [Related]

  • 25. The superior prognostic value of humoral factors compared with molecular proliferation markers in renal cell carcinoma.
    Lehmann J, Retz M, Nürnberg N, Schnöckel U, Raffenberg U, Krams M, Kellner U, Siemer S, Weichert-Jacobsen K, Stöckle M.
    Cancer; 2004 Oct 01; 101(7):1552-62. PubMed ID: 15378494
    [Abstract] [Full Text] [Related]

  • 26. Improving accuracy in the grading of renal cell carcinoma by combining the quantitative description of chromatin pattern with the quantitative determination of cell kinetic parameters.
    François C, Moreno C, Teitelbaum J, Bigras G, Salmon I, Danguy A, Brugal G, van Velthoven R, Kiss R, Decaestecker C.
    Cytometry; 2000 Feb 15; 42(1):18-26. PubMed ID: 10679739
    [Abstract] [Full Text] [Related]

  • 27. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T, Osaki T, Nose N, Ichiki Y, Inoue M, Imoto H, Yoshimatsu T, Kodate M, Uramoto H, Mizoue T, Yano K, Yasumoto K.
    Anticancer Res; 2000 Feb 15; 20(1B):505-10. PubMed ID: 10769714
    [Abstract] [Full Text] [Related]

  • 28. Prognostic value of proliferative activity of ovarian carcinoma as revealed by PCNA and AgNOR analyses.
    Ghazizadeh M, Sasaki Y, Araki T, Konishi H, Aihara K.
    Am J Clin Pathol; 1997 Apr 15; 107(4):451-8. PubMed ID: 9124214
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Evaluation of p53, PCNA, Ki-67, MDM2 and AgNOR in oral peripheral and central giant cell lesions.
    Souza PE, Mesquita RA, Gomez RS.
    Oral Dis; 2000 Jan 15; 6(1):35-9. PubMed ID: 10673786
    [Abstract] [Full Text] [Related]

  • 31. MCM - 2 and Ki - 67 as proliferation markers in renal cell carcinoma: A quantitative and semi - quantitative analysis.
    Mehdi MZ, Nagi AH, Naseem N.
    Int Braz J Urol; 2016 Jan 15; 42(6):1121-1128. PubMed ID: 27532114
    [Abstract] [Full Text] [Related]

  • 32. The prognostic importance of the nucleolar organizer region (AgNOR), Ki-67 and proliferating cell nuclear antigen (PCNA) in primary nonurachal bladder adenocarcinoma.
    Ozdemir BH, Ozdemir OG, Sertçelik A.
    APMIS; 2001 Jun 15; 109(6):428-34. PubMed ID: 11506474
    [Abstract] [Full Text] [Related]

  • 33. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
    Yu CC, Dublin EA, Camplejohn RS, Levison DA.
    Anal Cell Pathol; 1995 Jul 15; 9(1):45-52. PubMed ID: 7577754
    [Abstract] [Full Text] [Related]

  • 34. Incidence of apoptosis, cell proliferation and P53 expression in renal cell carcinomas.
    Tannapfel A, Hahn HA, Katalinic A, Fietkau RJ, Kühn R, Wittekind CW.
    Anticancer Res; 1997 Jul 15; 17(2A):1155-62. PubMed ID: 9137464
    [Abstract] [Full Text] [Related]

  • 35. Cell proliferation and apoptosis with BCL-2 expression in renal cell carcinoma.
    Zhang X, Takenaka I.
    Urology; 2000 Sep 01; 56(3):510-5. PubMed ID: 10962335
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.